Skip to content

13F-HR filed by Broadfin Capital, LLC

Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 53 holding rows worth $823,028,000.

Accession
0001511901-17-000005
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 53 entries on the cover page, a total value of $823,028,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $823,027,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerBroadfin Healthcare Master Fund Ltd 028-14254

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPDR SER TR78464A870S&P BIOTECH1,000,000$77,180,000thousands by filing dateput
HERON THERAPEUTICS INC427746102COM4,418,359$61,194,000thousands by filing date
RETROPHIN INC761299106COM2,862,178$55,498,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS4,060,847$48,202,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO4,133,464$45,592,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM5,184,942$37,487,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 21,257,887$37,447,000thousands by filing date
CORIUM INTL INC21887L107COM4,436,726$33,098,000thousands by filing date
IGNYTA INC451731103COM2,941,247$30,442,000thousands by filing date
ANGIODYNAMICS INC03475V101COM1,683,252$27,286,000thousands by filing date
ENDO INTL PLCG30401106SHS2,000,000$22,340,000thousands by filing datecall
SOCIETAL CDMO INC75629F109COM3,100,086$21,794,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,871,928$20,534,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM7,350,000$20,286,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW1,948,554$17,985,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM2,276,359$16,731,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM310,000$16,291,000thousands by filing date
ANTARES PHARMA INC036642106COM4,803,528$15,467,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock181,200$14,453,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM5,122,094$14,342,000thousands by filing date
ENDO INTL PLCG30401106SHS1,246,923$13,928,000thousands by filing date
TELIGENT INC NEW87960W104COM1,467,452$13,427,000thousands by filing date
Gilead Sciences,Inc.375558103COM180,000$12,740,000thousands by filing datecall
VERACYTE INC COM92337F107Stock1,446,866$12,052,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS1,000,000$11,870,000thousands by filing datecall
NOVADAQ TECHNOLOGIES INC COMMON66987G102COM1,000,000$11,720,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW2,533,649$10,211,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM2,490,801$9,091,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM262,100$7,834,000thousands by filing date
NEXVET BIOPHARMA PLCG6503X109ORD SHS1,127,200$7,541,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM1,000,000$6,790,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity277,020$6,676,000thousands by filing date
IDERA PHARMACEUTICALS INC45168K306COM3,852,945$6,627,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock816,275$6,122,000thousands by filing date
Egalet Corporation28226BAB0Note 5.50% 4/1/2010,000,000$5,031,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2150,000$4,466,000thousands by filing datecall
NUVASIVE INC670704105COM55,900$4,300,000thousands by filing date
HERON THERAPEUTICS INC427746102COM300,900$4,167,000thousands by filing datecall
NATUS MEDICAL INC639050103COM111,500$4,159,000thousands by filing date
PERNIX THERAPEUTICS HLDGS IN71426VAK4DBCV 4.250 4/015,000,000$3,999,000thousands by filing date
ZOGENIX INC.98978L204Common Stock262,500$3,806,000thousands by filing date
ENDOLOGIX INC29266S106COM779,341$3,788,000thousands by filing date
ARALEZ PHARMACEUTICALS INC03852X100COM2,034,103$2,746,000thousands by filing date
ADMA BIOLOGICS INC000899104COM681,346$2,521,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM221,848$2,476,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock52,700$2,239,000thousands by filing date
GLOBUS MED INC CL A379577208Stock66,700$2,211,000thousands by filing date
CONTRAFECT CORP212326102COM1,325,356$1,922,000thousands by filing date
COGENTIX MED INC COM19243A104Stock1,094,544$1,905,000thousands by filing date
MEDIWOUND LTDM68830104ORD SHS174,665$1,188,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW594,533$1,100,000thousands by filing date
OVASCIENCE INC69014Q101COM274,853$429,000thousands by filing date
DEXTERA SURGICAL INC COM252366109CS987,520$296,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001511901-17-000005this filing2017-08-14acceptance time not in the bulk data set
13F-HR/A 0001511901-17-000007 added2017-08-17acceptance time not in the bulk data set